Home / Health / Mixing Covaxin and Covishield induces four times more antibodies: Study

Mixing Covaxin and Covishield induces four times more antibodies: Study

The Spike-protein neutralizing antibodies found in the mixed vaccine groups were significantly higher than the same-vaccine groups

Covaxin, Covishield, serum institute of india, bharat biotech, vaccine, vaccination, coronavirus, covid

Premium

AIG Hospitals has shared the data from the study with the ICMR to be considered as a reference study while deciding on the prevention doses starting January 10

Sohini Das Mumbai

3 min read Last Updated : Jan 04 2022 | 12:45 AM IST

It is safe to mix Covishield (AstraZeneca vaccine) and Covaxin (Bharat Biotech vaccine) and mixing induces four times more antibodies than giving the same vaccine dose, showed a study conducted by a Hyderabad-based private hospital. The hospital has shared its findings with India’s apex health research body the Indian Council of Medical Research (ICMR).

A total of 330 healthy volunteers — who were not vaccinated and had no history of Covid-19 infection — were screened for SARS-CoV-2 antibodies for the study conducted by AIG Hospitals, along with researchers from the Asian Healthcare Foundation.

Of them, 44 (13 per cent) participants were found

Topics : Coronavirus Coronavirus Vaccine Coronavirus Tests

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in